JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111101200 on March 4, 2002

J. Biol. Chem., Vol. 277, Issue 20, 17597-17604, May 17, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/20/17597    most recent
M111101200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen-Hwang, M.-C.
Right arrow Articles by Hwang, Y.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen-Hwang, M.-C.
Right arrow Articles by Hwang, Y.-W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Dynamin Is a Minibrain Kinase/Dual Specificity Yak1-related Kinase 1A Substrate*

Mo-Chou Chen-HwangDagger , Huey-Ru Chen§, Marshall ElzingaDagger ||, and Yu-Wen HwangDagger §**DaggerDagger

From the Dagger  Molecular Biology Department, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314, § Department of Life Science, National Yang-Ming University, Pei-Tou, Taipei 112, Taiwan, and ** CSI/IBR Center for Developmental Neuroscience and Graduate Program in Biology, City University of New York, New York, New York 10016

Received for publication, November 20, 2001, and in revised form, February 28, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The minibrain kinase (Mnbk)/dual specificity Yak 1-related kinase 1A (Dyrk1A) gene is implicated in the mental retardation associated with Down's syndrome. It encodes a proline-directed serine/threonine kinase whose function has yet to be defined. We have used a solid-phase Mnbk/Dyrk1A kinase assay to aid in the search for the cellular Mnbk/Dyrk1A substrates. The assay revealed that rat brain contains two cytosolic proteins, one with a molecular mass of 100 kDa and one with a molecular mass of 140 kDa, that were prominently phosphorylated by Mnbk/Dyrk1A. The 100-kDa protein was purified and identified as dynamin 1. The conclusion was further supported by evidence that a recombinant glutathione S-transferase fusion protein containing dynamin isoform 1aa was phosphorylated by Mnbk/Dyrk1A. In addition to isoform 1aa, Mnbk/Dyrk1A also phosphorylated isoforms 1ab and 2aa but not human MxA protein when analyzed by the solid-phase kinase assay. Upon Mnbk/Dyrk1A phosphorylation, the interaction of dynamin 1 with the Src homology 3 domain of amphiphysin 1 was reduced. However, when Mnbk/Dyrk1A phosphorylation was allowed to proceed more extensively, the phosphorylation enhanced rather than reduced the binding of dynamin 1 to amphiphysin 1. The result suggests that Mnbk/Dyrk1A can play a dual role in regulating the interaction of dynamin 1 with amphiphysin 1. Mnbk/Dyrk1A phosphorylation also reduced the interaction of dynamin with endophilin 1, whereas the same phosphorylation enhanced the binding of dynamin 1 to Grb2. Nevertheless, the dual function of Mnbk/Dyrk1A phosphorylation was not observed for the interaction of dynamin 1 with endophilin 1 or Grb2. The interactions of dynamin with amphiphysin and endophilin are essential for the formation of endocytic complexes; our results suggest that Mnbk/Dyrk1A may function as a regulator controlling the assembly of endocytic apparatus.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Minibrain kinase (Mnbk)1 was originally identified in Drosophila as a mutation affecting neurogenesis (1). Mnbk mutant flies, which have low levels of kinase expression, possess fewer neuroblasts and a reduced brain volume as compared with the wild type (WT), especially in the optic lobes and central brain (1). The reduction in brain size leads to several distinct learning and behavioral defects. Because the Mnbk mutation does not appear to affect the development of Drosophila until late in the third instar, it was postulated that the Mnbk gene is required for the proliferation of neuroblasts during postembryonic neurogenesis (1).

Dual specificity Yak 1-related kinase (Dyrk) 1A was subsequently cloned (2-5) and identified as the mammalian homologue of the Drosophila Mnbk gene. The Mnbk/Dyrk1A gene is a member of a growing family of Dyrk-related genes (6) whose members include Yak1 (7), several Dyrks (8), ANPK (9), HIPK2 (10), Mirk (11), Myak (12), and Pom1p (13). Mammalian Mnbk/Dyrk1A gene contains either 763 or 754 amino acid residues as a result of alternative splicing (2). The kinase domain of Mnbk/Dyrk1A, consisting of ~320 residues, is located roughly in the center of the protein. In addition to the 11 subdomains characteristic of all protein kinases (14), the Mnbk/Dyrk1A kinase domain contains several signature motifs unique to the Dyrk family. These motifs include the sequence DFGSSC in subdomain VII, a substitution of a highly conserved arginine in subdomain VIB by cysteine, and a YXY motif between subdomains VII and VIII (6). Outside the kinase domain, Mnbk/Dyrk1A contains a bipartite nuclear target sequence (15), a PEST (proline, glutamate, serine, and threonine) region, a 13-residue histidine repeat, and a serine/threonine repeat near the C-terminal end. Little is known about the functions of these structural features except for the bipartite nuclear targeting sequence. The targeting sequence has been shown to guide overexpressed Mnbk/Dyrk1A into the nucleus (8, 16).

Several lines of evidence suggest that the Mnbk/Dyrk1A gene plays a role in causing the mental retardation phenotype of Down's syndrome. The human Mnbk/Dyrk1A gene maps to the q22.2 region of chromosome 21 (4, 17-20), a section of chromosome 21 known to associate with the mental retardation phenotype of Down's syndrome (21). Mnbk/Dyrk1A is highly expressed in the cortex, spinal cord, and olfactory bulb in developing mouse embryos. The patterns of Mnbk/Dyrk1A expression appear to correlate well with the regions of brain affected the most by Down's syndrome (3, 22). Significantly, when transgenic mice carry additional Mnbk/Dyrk1A genes, a situation mimicking Down's syndrome, the animals exhibit various learning and memory defects (23, 24).

Mnbk/Dyrk1A was originally proposed to be a dual specificity protein kinase (2). However, the dual specificity appears to be limited only to Mnbk/Dyrk1A autophosphorylation because the kinase is unable to phosphorylate tyrosine residues on exogenous substrates (8). By using histone and synthetic peptides as the target for phosphorylation, Mnbk/Dyrk1A was subsequently determined to be a proline-directed serine/threonine kinase, and the preferred phosphorylation site was identified as RPX(S/T)P (25). Several potential Mnbk/Dyrk1A substrates were recently identified. These substrates include eukaryotic initiation factor 2Bepsilon , the microtubule-associated protein tau, transcription factor forkhead in rhabdomyosarcoma, and the cAMP-response element-binding protein (26-28). Despite this progress, the roles of the Mnbk/Dyrk1A gene in cellular processes are far from established. To unveil its functions, we have conducted a generalized search for the kinase's substrates in rat brain. We show here that one of the major substrates in rat brain is dynamin 1 and that Mnbk/Dyrk1A phosphorylation modulates the interaction of dynamin with SH3 domain-containing proteins.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Clone Construction-- The full-length Mnbk/Dyrk1A gene was obtained by PCR from rat testis Quick-clone cDNA (CLONTECH) by using the following sequence-specific oligonucleotides, tctcatcgatgcatacaggaggagagacttcagcatgc and ctctctcgagtcacgagctagctacaggactctgttgcac, respectively, as the 5' and 3' primers for amplification. PCR produced a 2.3-kb amplicon, as expected for the full-length rat Mnbk/Dyrk1A gene. The PCR product was then digested with ClaI and XhoI (both restriction sites were introduced by the PCR primers) and cloned into restriction site-modified glutathione S-transferase (GST) fusion vector pGEX-3X, as described previously (29). The coding region of the cloned Mnbk/Dyrk1A gene was sequenced. We found two mismatches between our clone and the published sequence (2); both of them are silent. The sequencing also disclosed that our clone encodes the 754-residue isoform (2). A similar approach was used to construct GST fusion proteins containing the SH3 domain of human amphiphysin 1 (residues 545-696) (30) and the full-length human endophilin 1 (31, 32). The primer pair cctatcgatggccgacatcaagacgggcatcttcgc and cctctcgagctaatctaagcgtcgggtgaagttctc was used for amplifying amphiphysin 1, whereas the primer pair cctatcgatgtcggtggccggcctcaagaagcag and ggactcgagctaatggggcagggcaaccagaatttc was used for generating endophilin 1. GST-dynamin 1aa (rat), GST-dynamin 2aa (rat), and GST-MxA (human) clones were constructed from pCMV96-7 (33), pCMV96-7 (33), and p78/2-8b (34), respectively, by PCR and subcloning. Kinase-deficient GST-Mnbk/Dyrk1A harboring Y319F and Y321F double mutation (DF) was constructed by site-directed mutagenesis by using oligonucleotide gcgactctgaataaactggaatattctctgccccaa as the primer. The primer simultaneously converts both tyrosines to phenylalanines in a single step.

Preparation of the GST Fusion Proteins-- GST fusion proteins were expressed in Escherichia coli as described previously (29). We found that GST-Mnbk/Dyrk1A purified by nickel-nitrilotriacetic acid resin (which binds to the 13-histidine repeat of Mnbk/Dyrk1A) tends to have a higher specific activity than that prepared by glutathione resin; therefore, GST-Mnbk/Dyrk1A was routinely purified by using nickel-nitrilotriacetic acid resin as suggested by the manufacturer. All other GST fusion proteins were purified by using glutathione-Sepharose 4B as described previously (29). Protein concentration was determined by the Bradford method (35) with bovine serum albumin used as a standard.

Kinase Assays-- The solid-phase kinase assay (denatured assay) was performed as follows. Proteins to be tested were separated by SDS-PAGE (minigel) and then transferred onto Immobilon-P membranes (Millipore, Bedford, MA). After the transfer, membranes were blocked by shaking them in 20 ml of blocking buffer (25 mM HEPES, pH 7.5, 100 mM NaCl, 1.5% bovine serum albumin, and 0.05% sodium azide) at room temperature for 60 min. The blocked membrane was then washed once with 20 ml of 25 mM HEPES, pH 7.5, for 10 min at room temperature before subjecting it to kinase reaction. The reaction was performed by incubating the membrane with shaking in 3.5 ml of kinase buffer (25 mM HEPES, pH 7.5, 100 mM NaCl, 5 mM MgCl2, and 5 mM MnCl2) containing 5 µM cold ATP, 40 µCi of [gamma -32P]ATP (specific activity, 7000 Ci/mmol), and 10 µg of GST-Mnbk/Dyrk1A at room temperature for 60 min. The membranes were then washed as described by Ferrell and Martin (36) to reduce the background. Phosphorylated bands were detected by autoradiography. The solution kinase assay (native assay) was performed in a 30-µl reaction mixture containing kinase buffer, 1 µg of Sub-100 (dynamin 1), 5 µM ATP, and 2 µCi of [gamma -32P]ATP (7000 Ci/mmol) if needed. The reaction was initiated by the addition of GST-Mnbk/Dyrk1A and allowed to proceed at 30 °C. To determine the time course of phosphate incorporation, a 5-µl aliquot of reaction mixture was withdrawn at the indicated times, precipitated together with 100 µg of bovine serum albumin in 2 ml of silicotungstic acid (4% in 3 N sulfuric acid), collected onto a glass fiber filter (Whatman GF/B), and quantified by a scintillation counter. To determine the kinetic parameters of phosphorylation, Sub-100 (0.5-5 µg) was phosphorylated with 0.05 µg of GST-Mnbk/Dyrk1A for 10 min at 30 °C and quantified as described in the solution kinase assay. After correcting for the backgrounds (substrate and enzyme alone), the rate of phosphate incorporation was then used to fit the Michaelis-Menten equation to determine Vmax and Km for the phosphorylation reaction. The kcat was then calculated as Vmax/[Mnbk/Dyrk1A]. The data presented were the average of three independent assays.

Purification of Sub-100-- Sub-100 was purified from rat brain aqueous extracts as follows. All procedures were performed at either 0 °C or 4 °C unless stated otherwise. Adult rat brains (unstripped) were obtained from PelFreez Biological (Rogers, AK) and homogenized in homogenization buffer (3.5 ml/brain) containing 25 mM Tris-HCl, pH 7.4, 25 mM NaCl, 2 mM EDTA, 1 mM DTT, and 0.5 mM phenylmethylsulfonyl fluoride by using a glass Dounce homogenizer. This buffer released at least 50% of total cellular Sub-100. Brain lysate was obtained by centrifugation at 30,000 × g for 20 min, followed by a second centrifugation at 100,000 × g for 60 min. The recovered supernatant was dialyzed overnight against Tris-buffer A (25 mM Tris-HCl, pH 7.4, and 25 mM NaCl) plus 1 mM DTT and 0.5 mM phenylmethylsulfonyl fluoride. After removing precipitates by centrifugation (12,000 × g for 20 min), the brain lysate was loaded onto a Mono Q (HR 10/10) column (Amersham Biosciences) attached to a fast protein liquid chromatography. The column was then eluted with a 0-0.4 M NaCl gradient (0.02 M NaCl gradient/min in Tris-Buffer A and 1 mM DTT; flow rate, 3 ml/min) at room temperature, and 20 one-minute fractions were collected. Each fraction was analyzed for the presence of Sub-100 by the solid-phase kinase assay. Sub-100 was eluted from Mono Q column with 0.16-0.22 M NaCl. Sub-100 fractions were pooled and mixed with an equal volume of 3.2 M (NH4)2SO4 (at 0 °C), which quantitatively precipitates Sub-100. The precipitates were collected by centrifugation (12,000 × g for 10 min), dissolved in 3 ml of Tris-buffer A, and dialyzed overnight against 1000 ml of buffer containing 25 mM MES (pH 6.5), 25 mM NaCl, and 1 mM DTT. Sub-100 precipitated during dialysis. The precipitates were then collected by centrifugation and extracted three times with 100 µl of Tris-buffer A. This extraction recovered about 70% of the precipitated Sub-100 in solution. A final concentration of 100 mM NaCl was then added to Sub-100 solution to stabilize the protein. The proteins were stored at -70 °C until use. Purification of Sub-140 has been achieved recently and will be described elsewhere. Brain SDS extract was prepared by homogenizing rat brains in homogenization buffer containing 1% SDS followed by centrifugation at 30,000 × g for 20 min.

Protein Sequencing-- Sub-100 to be sequenced was further purified on an 8% Tricine SDS-PAGE gel and transferred onto an Immobilon-CD membrane (Millipore). The area of membrane containing Sub-100 was cut into small strips and placed into a 1.5-ml screw-cap microcentrifuge tube. Enough cyanogen bromide solution (20 mg/ml in 70% formic acid) to cover membrane strips was added to the tube, followed by incubation at room temperature under nitrogen and in the dark for 16 h. Digested peptides were recovered in formic acid, dried under vacuum, and then resolved on a 12% Tricine SDS-PAGE gel. Separated peptides were then transferred to an Immobilon-P membrane, stained with Coomassie Blue, and sequenced as membrane-bound material by using an Applied Biosystems automatic sequencer.

Protein-Protein Binding Assays-- Binding of dynamin to SH3 domain-containing proteins was performed as follows. Dynamin (1 µg) was first phosphorylated by 0.05-0.8 µg of GST-Mnbk/Dyrk1A in solution for 30 min at 30 °C, but no radioactive ATP was included in the reaction. The phosphorylated dynamin was then diluted with binding buffer (25 mM Tris, pH 7.4, 50 mM NaCl, 5 mM EDTA, and 1 mM DTT) to 200 µl and mixed with a 50-µl suspension of glutathione resin precoated with GST or GST fusion protein for 16 h at 4 °C. The resin was collected by centrifugation and washed five times by tumbling in the washing buffer (25 mM Tris, pH 7.4, 150 mM NaCl, and 1% Triton X-100) for 5 min at room temperature. Following the washings, the resin-bound proteins were eluted with 60 µl of buffer containing 100 mM Tris, pH 8.0, and 20 mM glutathione and subjected to Western blotting analysis. The blot was probed with mouse monoclonal anti-dynamin antibody Hudy-1 (37) (Upstate Biotechnology, Lake Placid, NY) (1:5000 dilution) and visualized by using sheep anti-mouse alkaline phosphatase-conjugated secondary antibody (Sigma) (1:5000 dilution) and CDP-Star chemiluminescence reagent (Applied Biosystems/Tropix, Foster City, CA). The quantitation of dynamin was performed by scanning x-ray films and analyzing the scanned images with the National Institutes of Health Image program. Precoating of glutathione resin with GST or GST fusion protein was prepared by incubation with tumbling of 200 µl (bed volume) of washed (twice with washing buffer) glutathione resin with 1.6 nmol of proteins at 4 °C for 4 h. The resin was then washed twice and resuspended to 25% slurry in washing buffer. Approximately 80-90% GST or GST fusion proteins bound to the resin, which is equivalent to at least 80 pmol GST or GST fusion proteins/50 µl resin suspension.

Brain cytosol was prepared by following the protocols described by Slepnev et al. (38). Phosphorylation was performed by incubating the cytosol at 30 °C for 30 min in the presence of 2 mM ATP, 2 mM MgCl2, 0.2-10 µg/ml either WT or DF GST-Mnbk/Dyrk1A (if needed), and a mixture of phosphatase inhibitors (2 µM cyclosporine, 0.2 µM okadaic acid, and 1 mM sodium orthovanadate). After stopping the reaction by the addition of 5 mM EDTA, the treated cytosol was then subjected to binding assay by mixing 0.5 ml of cytosol with 50 µl of glutathione resin precoated with GST proteins for 16 h at 4 °C. Bound dynamin was eluted from the resin and determined as described.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Development of the Mnbk/Dyrk1A Solid-phase Kinase Assay-- A rapid and reliable assay is essential for the purification of kinase substrates. Therefore, a solid-phase kinase assay was developed for Mnbk/Dyrk1A by adapting the combination of two previously described protocols (36, 39). Briefly, proteins to be tested are separated by SDS-PAGE, transferred onto a polyvinylidene difluoride membrane, blocked by bovine serum albumin, and then subjected to Mnbk/Dyrk1A phosphorylation in the presence of [gamma -32P]ATP. Under the conditions specified, the method detected 10 ng of immobilized myelin basic protein (MBP) (Fig. 1).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 1.   Phosphorylation of MBP by the solid-phase Mnbk/Dyrk1A assay. Different amounts of MBP were separated on a 10% Tricine-SDS gel, transferred to a polyvinylidene difluoride membrane, and phosphorylated as described under "Materials and Methods." Autoradiography was performed by exposing Kodak XAR 5 film with an intensifying screen for 3 h at -80 °C. The amount of MBP used in lanes 1-8 was 2.5, 5, 10, 20, 40, 80, 160, and 320 ng, respectively.

Detection of Mnbk/Dyrk1A Substrates in Rat Brain-- Rat brain aqueous extract was prepared and subjected to the solid-phase kinase assay. As shown in Fig. 2A, Mnbk/Dyrk1A prominently phosphorylated two proteins in adult rat brain: a 100-kDa protein (Sub-100) and a 140-kDa protein (Sub-140). In addition, several minor phosphorylated proteins were also detected in the assay. Phosphorylation of these two proteins did not appear to be due to autophosphorylation because no labeled protein was visible when the membrane was incubated without kinase (Fig. 2B). SDS (1%) extracted a few additional proteins that can be phosphorylated by Mnbk/Dyrk1A (Fig. 2C); nevertheless, Sub-100 and Sub-140 still represent the major cellular targets of Mnbk/Dyrk1A. In this study, we will concentrate on the identification and characterization of the 100-kDa Mnbk/Dyrk1A substrate.


View larger version (71K):
[in this window]
[in a new window]
 
Fig. 2.   Phosphorylation of rat brain soluble extract and SDS extract by the solid-phase Mnbk/Dyrk1A assay. Soluble and SDS extracts were prepared from adult rat brains and subjected to the solid-phase kinase assay (30 µg of total protein) as described under "Materials and Methods." A, phosphorylation of soluble extract; B, phosphorylation of soluble extract without kinase; C, phosphorylation of SDS extract with kinase.

Purification of the 100-kDa Mnbk/Dyrk1A Substrate, Sub-100-- By using the solid-phase kinase assay to monitor the process of Sub-100 purification (see "Materials and Methods"), Sub-100 was purified from adult rat brains under native conditions (Fig. 3A). Like the denatured Sub-100 used in the solid-phase assay, purified Sub-100 was efficiently phosphorylated by Mnbk/Dyrk1A under native conditions. This result suggests that the Mnbk/Dyrk1A phosphorylation site on Sub-100 is naturally exposed. The extent of phosphate incorporation was highly dependent on the GST-Mnbk/Dyrk1A concentration (Fig. 3B). The molar ratio of phosphate incorporation would only reach a certain level if Sub-100 was incubated with a low amount of kinase. On the other hand, the ratio could easily exceed 1 if a high level of kinase was used for the assay. By using native Sub-100 as a substrate and a constant kinase level of 0.05 µg/assay, the apparent Km and kcat values of the reaction were determined to be 1.17 µM and 0.15 s-1, respectively.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   Purification and phosphorylation of native Sub-100 by GST-Mnbk/Dyrk1A. A, Coomassie Blue staining of purified Sub-100. B, time course of phosphate incorporation. Purified native Sub-100 (1 µg) was phosphorylated by GST-Mnbk/Dyrk1A (0.05-0.8 µg) in the solution kinase assay in a total volume of 30 µl. At the indicated times, a 5-µl aliquot of labeled Sub-100 was withdrawn and precipitated with silicotungstic acid and quantified as described under "Materials and Methods." Parallel experiments, performed with Sub-100 alone and with kinase alone, were used for background correction. The numbers represent the average of three independent experiments. The amounts of GST-Mnbk/Dyrk1A used for the assays were 0.05 (), 0.1 (black-square), 0.4 (black-diamond ), and 0.8 µg (black-triangle).

Identification of Sub-100 kDa as Dynamin 1-- Because Sub-100 could not be sequenced directly, it was first cleaved with cyanogen bromide. Cyanogen bromide cleaves Sub-100 into eight visible fragments with apparent molecular masses ranging from 4 to 16 kDa (4.5, 5, 6, 8, 10, 11, 13, and 16 kDa) when analyzed on a 12.5% SDS-Tricine gel (polypeptides smaller than 4 kDa were not resolved by this gel). Edman degradation showed that the largest fragment, the 16-kDa polypeptide, contained the sequence (M)(T/E)DLIPLVNRL. BLAST search identified this fragment as unique to rat dynamin 1. This 16-kDa fragment corresponds to the 135-residue peptide (calculated mass, 14,528 Da) resulting from cyanogen bromide cleavage at methionine-4 and methionine-140 of dynamin 1. Then the 6-kDa peptide was sequenced and found to contain the sequence (M)DEGXDAR. This sequence again matches dynamin, but it is common to all dynamin isoforms. Dynamins are encoded by three distinct genes, each expressed as several closely related spliced variants (40). We inferred that Sub-100 is primarily, if not exclusively, dynamin 1 based on the following reasoning. First, Sub-100 matches dynamin 1 in size and contains a dynamin 1-specific peptide. Second, dynamin 1 is the dominating isoform in brain, the source for Sub-100. Third, Sub-100 precipitates at pH 6.5 ("Materials and Methods"), which is consistent with the isoelectric point of dynamin 1 but not with that of dynamin 2 and dynamin 3. Fourth, Sub-100 lacks the larger cyanogen bromide-cleavable peptide (calculated mass, 16,825 Da) predicated from the sequence of dynamin 2, which indicates that Sub-100 does not contain a significant amount of dynamin 2. For convenience, Sub-100 will be referred to as dynamin 1.

Phosphorylation of E. coli-expressed Dynamin Isoforms by Mnbk/Dyrk1A-- To confirm that dynamin 1 is an Mnbk/Dyrk1A substrate, a GST fusion clone containing the dynamin 1aa isoform was constructed from plasmid pCMV96-7 (33). Upon induction, the clone produced a 125-kDa protein (Fig. 4A, 1), which can be recognized by anti-human dynamin monoclonal antibody Hudy-1 (37) (data not shown). This protein was then analyzed by the solid-phase kinase assay. As shown in Fig. 4B, 1, GST-dynamin 1aa was phosphorylated by Mnbk/Dyrk1A similarly to the purified rat brain dynamin 1. This observation substantiates the conclusion that dynamin 1aa is a Mnbk/Dyrk1A substrate. In addition to isoform 1aa, Mnbk/Dyrk1A also phosphorylated dynamin-1ab (data not shown) and dynamin 2aa (Fig. 4, A and B, 2) under the same condition. Dynamin 1ab is identical to the 1aa isoform except for 20 or so residues at the C terminus, whereas dynamin 2 shares about 78% overall homology with dynamin 1. In contrast, human MxA protein, a distant dynamin homologue that is inducible by type 1 interferon and some viruses (34), was not a Mnbk/Dyrk1A substrate (Fig. 4, A and B, 3).


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 4.   The production and phosphorylation of dynamin isoforms and the MxA protein. GST fusion proteins were expressed in E. coli strain BL21(DE3) as described under "Materials and Methods." Cells from 200-µl aliquots were collected by centrifugation, boiled in 0.5 volume of SDS-PAGE loading buffer, and electrophoresed on duplicate 8% Tricine-SDS gels. One gel was stained with Coomassie Blue (A), and the other was blotted and subjected to solid-phase Mnbk/Dyrk1A phosphorylation (B). IPTG -, controls; IPTG +, isopropyl-beta -D-thiogalactopyranoside-induced samples. Asterisks indicate the induced GST fusion proteins. 1, GST-dynamin 1aa; 2, GST-dynamin 2aa; 3, GST-MxA.

Effects of Mnbk/Dyrk1A Phosphorylation on the Interaction of Purified Dynamin 1 with Amphiphysin-- The binding of dynamin to amphiphysin is required for incorporation of dynamin into endocytic complexes (41). The interaction is inhibited when dynamin is phosphorylated (38). However, the kinase (or kinases) responsible for the dynamin phosphorylation has not been identified. Therefore, it was of interest to test whether Mnbk/Dyrk1A could assume the role of the unknown kinase. To perform the experiment, purified rat brain dynamin 1 was phosphorylated by Mnbk/Dyrk1A in solution and then allowed to bind to the immobilized GST fusion protein containing the SH3 domain of human amphiphysin 1, GST-Amp(SH3). After recovering the immobilized GST-Amp(SH3), the presence of dynamin in the complex was determined with the anti-dynamin antibody Hudy-1. As expected, GST-Amp(SH3) bound dynamin 1 as opposed to the GST control (Fig. 5A). Interestingly, the ability to bind GST-Amp(SH3) was reduced when dynamin was phosphorylated by GST-Mnbk/Dyrk1A before the assay (Fig. 5A). The reduction in binding required the dynamin phosphorylating activity of GST-Mnbk/Dyrk1A because DF, a mutant protein possessing a fraction of catalytic activity of the WT (2), had little inhibitory effect on the binding (Fig. 5A). The reduction in the binding could not be attributed to the direct competition from GST-Mnbk/Dyrk1A because it did not form a stable complex with dynamin 1 under the assay conditions (Fig. 6). Because antibody Hudy-1 cannot distinguish between Mnbk/Dyrk1A-phosphorylated and nonphosphorylated dynamin 1 (Fig. 7), it further ruled out the possibility that the reduction observed (Fig. 5A) was caused by the inability of Hudy-1 to recognize the Mnbk/Dyrk1A-phosphorylated dynamin 1. 


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 5.   Interaction of Mnbk/Dyrk1A-phosphorylated dynamin with the SH3 domain of amphiphysin 1. A, amphiphysin binding property of phosphorylated dynamin. Purified dynamin 1 (1 µg) was phosphorylated by 0.1 µg of Mnbk/Dyrk1A and then bound to glutathione resin precoated with GST or GST-Amp(SH3) as described under "Materials and Methods." After binding, glutathione resin was collected, and co-precipitated dynamin was detected by anti-dynamin antibody. Dynamin incubated with ATP but without the addition of kinase was used as the phosphorylation control. GST, experiment performed with GST-coated resin; Amp(SH3), experiment performed with GST-Amp(SH3)-coated resin. ATP, control phosphorylation with ATP alone; DF, phosphorylated by GST-Mnbk/Dyrk1A double mutant plus ATP; WT, phosphorylated by wild-type GST-Mnbk/Dyrk1A plus ATP. Bars, which have been normalized to the ATP control (ATP control = 1), represent the mean ± S.D. of three independent experiments. A paired t test was performed for the treatment pairs ATP-WT, DF-WT, and ATP-DF. ATP and DF were found to be statistically different from WT (*, p < 0.01), whereas no difference was found between ATP and DF. B, amphiphysin binding of dynamin phosphorylated by different concentrations of Mnbk/Dyrk1A. Purified dynamin 1 (1 µg) was phosphorylated with either 0, 0.1, 0.4, or 0.8 µg of WT Mnbk/Dyrk1A and then subjected to the amphiphysin binding assay as described above. Dynamin 1 treated with 0. 1 or 0.8 µg of WT Mnbk/Dyrk1A was found to be significantly different from the untreated control in binding amphiphysin (*, p < 0.01, paired t test).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 6.   Binding assay of dynamin 1 to GST-Mnbk/Dyrk1A. Binding was performed by mixing 1 µg of dynamin 1 and 10 µg of GST-Mnbk/Dyrk1A in a buffer containing 25 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, and 1 mM DTT. GST-Mnbk/Dyrk1A in the binding mixture was subsequently precipitated with glutathione resin, and the presence of dynamin in the complex was detected by anti-dynamin antibody as described under "Materials and Methods." Negative and positive controls were performed similarly by using GST and GST-Amp(SH3), respectively, as the binding agents. Lane 1, GST; lane 2, GST-Mnbk/Dyrk1A; lane 3, GST-Amp(SH3).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 7.   Detection of control and Mnbk/Dyrk1A-phosphorylated dynamin by anti-dynamin antibody Hudy-1. Purified dynamin 1 (1 µg) was phosphorylated by 0.1 µg of Mnbk/Dyrk1A and then subjected to Western blotting analysis by anti-dynamin antibody Hudy-1 as described under "Materials and Methods." Each lane presents 20 ng of control (C) and Mnbk/Dyrk1A-phosphorylated dynamin (P).

Intriguingly, if dynamin was phosphorylated with higher concentrations of Mnbk/Dyrk1A (Fig. 5B), specifically with an amount of Mnbk/Dyrk1A that was able to promote >1 mol phosphate incorporation/mol of dynamin (Fig. 3B), the phosphorylation resulted in enhancement rather than reduction of the binding of dynamin to GST-Amp(SH3). This observation suggests that Mnbk/Dyrk1A phosphorylation plays a dual role in regulating the amphiphysin binding property of dynamin.

Effects of Mnbk/Dyrk1A Phosphorylation on the Interaction of Dynamin with Amphiphysin in Crude Brain Extract-- We further examined the effects of Mnbk/Dyrk1A phosphorylation on dynamin-amphiphysin binding in crude brain extracts. A low-salt aqueous extract (cytosol) containing many proteins involved in endocytosis was prepared from adult rat brains by following the protocols of Slepnev et al. (38). After incubation with ATP and phosphatase inhibitors, cytosol was mixed with resin-immobilized GST-Amp(SH3), and the amount of dynamin co-precipitated with the resin was analyzed. As opposed to the Triton X-100 extract (38), the addition of ATP and phosphatase inhibitors did not cause an appreciable reduction in the binding of dynamin to GST-Amp(SH3) (data not shown). This result suggests that the cytosol fraction lacked the necessary kinase to modulate the binding of dynamin to GST-Amp(SH3). Therefore, the cytosol was used for testing the effects of GST-Mnbk/Dyrk1A supplementation on the binding of dynamin to GST-Amp(SH3). Similarly to purified dynamin 1 (Fig. 5), the addition of the wild-type GST-Mnbk/Dyrk1A, ATP, and phosphatase inhibitors inhibited the binding of dynamin to GST-Amp(SH3) (Fig. 8). Again, GST-DF had little effect on the binding, indicating that the kinase activity is essential for the inhibition of dynamin-amphiphysin binding (Fig. 8). This result shows that Mnbk/Dyrk1A phosphorylation can inhibit dynamin-amphiphysin binding in a defined as well as in a more complex system, such as crude brain extract. When cytosol was treated with a higher concentration of Mnbk/Dyrk1A, more dynamin was found to bind GST-Amp(SH3) than the untreated control (data not shown). Thus, the dual effect of Mnbk/Dyrk1A phosphorylation on dynamin and GST-Amp(SH3) binding was also observed in crude extract.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 8.   The effects of GST-Mnbk/Dyrk1A phosphorylation on dynamin 1 binding to amphiphysin 1, endophilin 1, and Grb2 in brain cytosolic extract. Rat brain cytosol was incubated with either WT GST-Mnbk/Dyrk1A or DF in the presence of ATP and phosphatase inhibitors as described under "Materials and Methods." An extract incubated without kinase (ATP) was used as a phosphorylation control. After reaction, samples were mixed with glutathione resin precoated with either GST-Amp(SH3), GST-endophilin 1, or GST-Grb2 and processed as described in the Fig. 7 legend. The volume of eluted sample used for Western blotting analysis was adjusted to give a roughly equal intensity of the dynamin band. Amp(SH3), Endophilin 1, and Grb 2 represent experiments performed with glutathione resin coated with GST-Amp(SH3), GST-endophilin 1, and GST-Grb2, respectively. ATP, extract incubated with ATP and phosphatase inhibitors but no kinase; DF, phosphorylated by GST-Mnbk/Dyrk1A double mutant plus ATP and phosphatase inhibitors; WT, phosphorylated by wild-type GST-Mnbk/Dyrk1A plus ATP and phosphatase inhibitors. Bars, which have been normalized to the ATP control (ATP control = 1) in each set of the binding assay, represent the mean ± S.D. of three independent experiments. A paired t test was performed for the treatment pairs ATP-WT, DF-WT, and ATP-DF. In all three binding assays, statistical differences were found between ATP (or DF) and WT (*, p < 0.01), but not between ATP and DF.

Effects of Mnbk/Dyrk1A Phosphorylation on the Interaction of Dynamin with Endophilin 1 and Grb2 in Crude Brain Extract-- We then analyzed whether Mnbk/Dyrk1A phosphorylation affected the binding of dynamin to other SH3 domain-containing proteins. Endophilin 1 (SH3p4) (42) and Grb2 (43) were chosen for the study because of their roles in mediating the cellular function of dynamin. To perform the assay, GST fusion of full-length human endophilin 1 and Grb2 was prepared, immobilized onto resin, and used as the affinity matrix for binding dynamin. Both endophilin 1 and Grb2 bound dynamin under the same assay conditions used for analyzing dynamin-GST-Amp(SH3) binding (Fig. 8). Similarly to GST-Amp(SH3), Mnbk/Dyrk1A phosphorylation reduced the binding of dynamin to endophilin 1 (Fig. 8). In contrast, Mnbk/Dyrk1A phosphorylation has an opposite effect on dynamin-Grb2 binding because it enhanced rather than reduced the binding of dynamin to Grb2 (Fig. 8). GST-DF had little effect on the binding of dynamin to either endophilin 1 or Grb2 (Fig. 8). Again, it showed that an active kinase activity was required for modifying the property of dynamin. However, the dual effect of Mnbk/Dyrk1A phosphorylation on dynamin was not observed for binding to endophilin 1 and Grb2 (data not shown).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

A solid-phase kinase assay for analyzing substrates of Mnbk/Dyrk1A was developed and used to probe rat brain extract (Fig. 1). Two cytosolic substrates of Mnbk/Dyrk1A, one of 100 kDa and the other of 140 kDa, were revealed by the assay (Fig. 2). The 100-kDa protein was purified and determined to be dynamin 1. It was further confirmed that dynamin 1 is a Mnbk/Dyrk1A substrate by showing that recombinant GST-dynamin 1 proteins (both the dynamin 1aa and 1ab isoforms) were efficiently phosphorylated by Mnbk/Dyrk1A (Fig. 4). In addition to dynamin 1, Mnbk/Dyrk1A was also shown to phosphorylate recombinant GST-dynamin 2aa but not the human MxA protein in the solid-phase assay (Fig. 4). Mnbk/Dyrk1A is capable of phosphorylating native dynamin (Fig. 3B), indicating that phosphorylation sites are naturally accessible to the kinase. The extent of phosphorylation was highly dependent on the amounts of input kinase (Fig. 3B). For example, a high phosphorylation ratio could not be achieved even with prolonged incubation if one started with a low level of kinase (Fig. 3B). This phenomenon may be attributed to the fact that purified GST-Mnbk/Dyrk1A is rather unstable in vitro. Dynamin can be phosphorylated to >1 mol phosphate/mol protein if sufficient kinase is present. The observation implies that dynamin may contain multiple Mnbk/Dyrk1 phosphorylation sites. By using a constant level of 0.05 µg of Mnbk/Dyrk1A, the Km and kcat values of the phosphorylation reaction were determined to be 1.17 µM and 0.15 s-1, respectively. These values are similar to those of Mnbk/Dyrk1A phosphorylation of MBP (25).

Dynamin is a large GTPase known to play an essential role in clathrin-mediated endocytosis and synaptic vesicle recycling (40, 41, 44). It has been proposed that dynamin, which assembled around the necks of invaginated clathrin-coated pits, is responsible for constricting and pinching coated vesicles from the plasma membrane through a concerted conformational change (45-48). However, evidence also exists that dynamin may function as a regulator in receptor-mediated endocytosis rather than as a mechanochemical enzyme directly involved in generating vesicles (49). Dynamins consist of four recognizable structural domains: a highly conserved GTPase domain in the first 300 residues, a pleckstrin homology domain, a GTPase effector domain, and the least conserved proline-rich domain at the C terminus (40, 41, 44). Dynamin binds either in vitro or in vivo to a large array of cellular components, including proteins participating in endocytosis, maintenance of the cytoskeleton, and signal transduction, primarily through its pleckstrin homology domain and proline-rich domain (40, 41, 44).

Mnbk/Dyrk1A phosphorylation of dynamin 1 appears to have physiological significance. First, dynamin 1 was phosphorylated by Mnbk/Dyrk1A in its native state to a stoichiometric ratio (Fig. 3B). Most importantly, the phosphorylation inhibited the binding of dynamin to amphiphysin 1 (Fig. 5A). Both amphiphysin and dynamin 1 are highly enriched in nerve terminals, and they are the major binding partners to each other (50). By virtue of its ability to interact with various components of endocytic complexes, such as clathrin, adaptins, synaptojanin, and others, amphiphysin appears to function as an adapter protein for incorporating dynamin into the endocytic apparatus (41, 51). In neuronal cells, dynamin undergoes an activity-dependent phosphorylation-dephosphorylation cycle: it is phosphorylated when the cell is in the resting state and is rapidly dephosphorylated when the cell is depolarized (52, 53). It has been shown that phosphorylation of dynamin inhibits its interaction with amphiphysin and the subsequent incorporation into the endocytic apparatus (38). The kinase (or kinases) responsible for the phosphorylation has not been identified. Our results demonstrate that Mnbk/Dyrk1A can fulfill the role of the unidentified kinase in vitro.

Mnbk/Dyrk1A appears to play a dual role in mediating dynamin and amphiphysin binding (Fig. 5B). When dynamin was phosphorylated by a low concentration of Mnbk/Dyrk1A, the dynamin-amphiphysin binding was inhibited by the phosphorylation. However, if dynamin was phosphorylated with a larger amount of Mnbk/Dyrk1A, the phosphorylation resulted in the enhancement of dynamin binding to amphiphysin. The amount of Mnbk/Dyrk1A needed for the changeover appeared to be between 0.1 and 0.4 µg Mnbk/Dyrk1A/µg dynamin 1 (Fig. 5B). This level of kinase is roughly equivalent to the concentration required for promoting >1 mol phosphate incorporation/mol dynamin (Fig. 3B). The level of phosphate incorporation and the ability to bind amphiphysin must be related; therefore, we speculate that dynamin may contain two Mnbk/Dyrk1A phosphorylation sites, which are phosphorylated by Mnbk/Dyrk1A with different rates (or recognized by Mnbk/Dyrk1A with different affinities). Phosphorylation at the fast site can be achieved with low kinase concentrations and accounts for the reduction in amphiphysin binding, whereas phosphorylation at the slow site can only be obtained with high kinase concentrations and can reverse the effects of the fast site phosphorylation. This hypothesis explains the dual effect of Mnbk/Dyrk1A phosphorylation. Apparently, the slow site phosphorylation does not influence the binding of dynamin to endophilin 1 and Grb2 because these bindings are not affected by the level of dynamin phosphorylation. Furthermore, the determined Km and kcat values probably represent the phosphorylation of the fast site because the experiments were performed with a low concentration of kinase. Because the level of residual phosphorylation in purified rat dynamin 1 was not determined, alternatively, the property of dynamin 1 phosphorylated with varying amounts of Mnbk/Dyrk1A may reflect distinct sensitivities of different phosphorylation sites to dephosphorylation during dynamin 1 purification.

Mnbk/Dyrk1A phosphorylation also reduced the interaction of dynamin with endophilin 1 (Fig. 8). Like amphiphysin, endophilin 1 is highly enriched in nerve terminals (42, 54). Studies suggest that this protein may be involved in multiple steps of synaptic vesicle recycling, ranging from clathrin-coated vesicle invagination to fission and possibly to the uncoating of vesicles (55, 56). To accomplish these functions, endophilin 1 appears to require the lysophosphatidic acid acyltransferase activity of endophilin 1 as well as the direct participation of dynamin (57). The finding that Mnbk/Dyrk1A phosphorylation inhibits dynamin and endophilin1 binding further suggests a potential role for the kinase in the endocytic pathways.

Mnbk/Dyrk1A phosphorylation enhanced the interaction of dynamin with Grb2. The role of the Grb2 in tyrosine kinase signal transduction is well established (58). Grb2 consists solely of SH2 and SH3 domains and serves as an adaptor linking different signal transduction pathways, such as receptor tyrosine kinases and the mitogen-activated protein kinase cascade. The ability of Grb2 to bind dynamin implies an involvement of dynamin in the tyrosine kinase signaling pathway. Studies have shown that the dynamin-Grb2 interaction recruits dynamin to the insulin signaling complex and subsequently promotes tyrosine phosphorylation of dynamin (59, 60). Furthermore, dynamin may also participate in the signaling pathways of G-protein-coupled receptors through interaction with Grb2. G-protein-coupled receptor, such as beta 2-adrenergic receptor, is known to associate with Grb2 as a result of tyrosine phosphorylation on G-protein-coupled receptor (61). Conceivably, the dynamin-Grb2 interaction could bring dynamin to phosphorylated G-protein-coupled receptor and promote receptor internalization, which may subsequently lead to termination of receptor signaling (61) or stimulation of the downstream kinase cascade for some receptors (62). These connections indicate that Mnbk/Dyrk1A may regulate the signal transduction pathway of receptors through dynamin phosphorylation.

Mnbk/Dyrk1A has been shown to be a proline-directed kinase (25). This conclusion is consistent with our preliminary data showing that all Mnbk/Dyrk1A phosphorylation sites appear to be localized in the proline-rich domain of dynamin 1.2 This may also explain why MxA, a protein lacking proline-rich domain, was not a Mnbk/Dyrk1A substrate (Fig. 4). With the use of histone and synthetic combinatorial peptides, it was determined that Mnbk/Dyrk1A preferentially phosphorylates a site with the sequence RPX(S/T)P (25). Dynamin 1xa isoforms contain the sequence 854RPESP858, localized near the C-terminal end (33, 53). Interestingly, the sequence is located about 14 residues away from the overlapping amphiphysin and endophilin 1 binding sites of dynamin 1 (63, 64). Nevertheless, it should be pointed out that although both dynamin 1ab and dynamin 2aa isoforms are efficiently phosphorylated by Mnbk/Dyrk1A in the solid-phase assay, the sequence RPX(S/T)P is not present in either isoform. Clearly, Mnbk/Dyrk1A allows certain degrees of variation for its phosphorylation site. Work to map the Mnbk/Dyrk1A phosphorylation sites on dynamin is currently under way.

On the basis of its ability to phosphorylate dynamin and modulate its interaction with amphiphysin and endophilin, we suggest that Mnbk/Dyrk1A is involved in regulating synaptic vesicle recycling. Disrupting the function of dynamin has been shown to affect the synaptic activity required for memory retrieval in Drosophila (65, 66). Our findings shed light on animal model studies reporting that either over- or underexpression of the Mnbk/Dyrk1A gene caused behavioral, learning, and cognitive defects (1, 23, 24).

    ACKNOWLEDGEMENTS

We thank Dr. Thomas C. Südhof (Howard Hughes Medical Institute, University Texas Southwestern Medical Center) for providing dynamin clones (pCMV96-7 and pCMV96-15). We also thank Drs. Robert Denman, Carl Dobkin, David Miller, and Noriko Murakami for critical reading of the manuscript and Maureen Marrow for editorial assistance. Y.-W. H. thanks Drs. Ming-Ta Hsu (Department of Life Science, National Yang-Ming University), Yun-Chia Chou (Institute of Physiology, National Yang-Ming University), and Chen-Kung Chou (Taipei Veterans General Hospital) for support during his tenure in Taiwan.

    FOOTNOTES

* This work was supported in part by the New York State Office of Mental Retardation and Developmental Disabilities and by National Institutes of Health Grants HD35870 (to Y.-W. H.) and HD38295 (to Y.-W. H.). Additional support was provided by the Yen Tjing Ling Medical Foundation (Taiwan) and by Grant NSC-87-2312-B-010-005 (to Y.-W. H.) from the National Science Council (Taiwan).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Present address: Dept. of Aquaculture, National Suao Marine & Fishery Senior Vocational School, Suao, Taiwan.

|| Present address: 6010 Summerhill Dr., Hudsonville, MI 49426.

Dagger Dagger To whom correspondence should be addressed: Molecular Biology Dept., New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Rd., Staten Island, NY 10314. Tel.: 718-494-5337; Fax: 718-494-5905; E-mail: hwang@postbox.csi.cuny.edu.

Published, JBC Papers in Press, March 4, 2002, DOI 10.1074/jbc.M111101200

2 J. Y. Huang, M.-C. Chen-Hwang, N. Murakami, R. Wang, and Y. W. Hwang.

    ABBREVIATIONS

The abbreviations used are: Mnbk, minibrain kinase; Amp(SH3), Src homology 3 domain of amphiphysin 1; DTT, dithiothreitol; Dyrk, dual specificity Yak-related kinase; FPLC, fast protein liquid chromatography; GST, glutathione S-transferase; MBP, myelin basic protein; SH, Src homology; WT, wild type; MES, 4-morpholineethanesulfonic acid; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Tejedor, F., Zhu, X. R., Kaltenbach, E., Ackermann, A., Baumann, A., Canal, I., Heisenberg, M., Fischbach, K. F., and Pongs, O. (1995) Neuron 14, 287-301[CrossRef][Medline] [Order article via Infotrieve]
2. Kentrup, H., Becker, W., Heukelbach, J., Wilmes, A., Schürmann, A., Huppertz, C., Kainulainen, H., and Joost, H. G. (1996) J. Biol. Chem. 271, 3488-3495[Abstract/Free Full Text]
3. Guimerà, J., Casas, C., Pucharcòs, C., Solans, A., Domènech, A., Planas, A. M., Ashley, J., Lovett, M., Estivill, X., and Pritchard, M. A. (1996) Hum. Mol. Genet. 5, 1305-1310[Abstract/Free Full Text]
4. Shindoh, N., Kudoh, J., Maeda, H., Yamaki, A., Minoshima, S., Shimizu, Y., and Shimizu, N. (1996) Biochem. Biophys. Res. Commun. 225, 92-99[CrossRef][Medline] [Order article via Infotrieve]
5. Song, W. J., Sternberg, L. R., Kasten-Sportès, C., Van Keuren, M. L., Chung, S. H., Slack, A., Miller, D. E., Glover, T. W., Chiang, P. W., Lou, L., and Kurnit, D. M. (1996) Genomics 38, 331-339[CrossRef][Medline] [Order article via Infotrieve]
6. Becker, W., and Joost, H. G. (1999) Prog. Nucleic Acid Res. Mol. Biol. 62, 1-17[Medline] [Order article via Infotrieve]
7. Garrett, S., and Broach, J. R. (1989) Genes Dev. 3, 1336-1348[Abstract/Free Full Text]
8. Becker, W., Weber, Y., Wetzel, K., Eirmbter, K., Tejedor, F. J., and Joost, H. G. (1998) J. Biol. Chem. 273, 25893-25902[Abstract/Free Full Text]
9. Moilanen, A. M., Karvonen, U., Poukka, H., Janne, O. A., and Palvimo, J. J. (1998) Mol. Biol. Cell 9, 2527-2543[Abstract/Free Full Text]
10. Hofmann, T. G., Mincheva, A., Lichter, P., Droge, W., and Lienhard Schmitz, M. (2000) Biochimie (Paris) 82, 1123-1127
11. Lee, K., Deng, X., and Friedman, E. (2000) Cancer Res. 60, 3631-3637[Abstract/Free Full Text]
12. Shang, E., Wang, X., Huang, J., Yoshida, W., Kuroiwa, A., and Wolgemuth, D. J. (2000) Mol. Reprod. Dev. 55, 372-378[CrossRef][Medline] [Order article via Infotrieve]
13. Bahler, J., and Nurse, P. (2001) EMBO J. 20, 1064-1073[CrossRef][Medline] [Order article via Infotrieve]
14. Hanks, S. K., Quinn, A. M., and Hunter, T. (1988) Science 241, 42-52[Abstract/Free Full Text]
15. Dingwall, C., and Laskey, R. A. (1991) Trends Biochem. Sci. 16, 478-481[CrossRef][Medline] [Order article via Infotrieve]
16. Song, W. J., Chung, S. H., and Kurnit, D. M. (1997) Biochem. Biophys. Res. Commun. 231, 640-644[CrossRef][Medline] [Order article via Infotrieve]
17. Guimerà, J., Pritchard, M., Nadal, M., and Estivill, X. (1997) Cytogenet. Cell Genet. 77, 182-184[Medline] [Order article via Infotrieve]
18. Ohira, M., Seki, N., Nagase, T., Suzuki, E., Nomura, N., Ohara, O., Hattori, M., Sakaki, Y., Eki, T., Murakami, Y., Saito, T., Ichikawa, H., and Ohki, M. (1997) Genome Res. 7, 47-58[Abstract/Free Full Text]
19. Chen, H., and Antonarakis, S. E. (1997) Hum. Genet. 99, 262-265[CrossRef][Medline] [Order article via Infotrieve]
20. Hattori, M., Fujiyama, A., Taylor, T. D., Watanabe, H., Yada, T., Park, H. S., Toyoda, A., Ishii, K., Totoki, Y., Choi, D. K., Soeda, E., Ohki, M., Takagi, T., Sakaki, Y., Taudien, S., Blechschmidt, K., Polley, A., Menzel, U., Delabar, J., Kumpf, K., Lehmann, R., Patterson, D., Reichwald, K., Rump, A., Schillhabel, M., Schudy, A., Zimmermann, W., Rosenthal, A., Kudoh, J., Schibuya, K., Kawasaki, K., Asakawa, S., Shintani, A., Sasaki, T., Nagamine, K., Mitsuyama, S., Antonarakis, S. E., Minoshima, S., Shimizu, N., Nordsiek, G., Hornischer, K., Brant, P., Scharfe, M., Schon, O., Desario, A., Reichelt, J., Kauer, G., Blocker, H., Ramser, J., Beck, A., Klages, S., Hennig, S., Riesselmann, L., Dagand, E., Haaf, T., Wehrmeyer, S., Borzym, K., Gardiner, K., Nizetic, D., Francis, F., Lehrach, H., Reinhardt, R., and Yaspo, M. L. (2000) Nature 405, 311-319[CrossRef][Medline] [Order article via Infotrieve]
21. Kola, I., and Hertzog, P. J. (1998) Curr. Opin. Genet. Dev. 8, 316-321[CrossRef][Medline] [Order article via Infotrieve]
22. Rahmani, Z., Lopes, C., Rachidi, M., and Delabar, J. M. (1998) Biochem. Biophys. Res. Commun. 253, 514-518[CrossRef][Medline] [Order article via Infotrieve]
23. Smith, D. J., Stevens, M. E., Sudanagunta, S. P., Bronson, R. T., Makhinson, M., Watabe, A. M., O'Dell, T. J., Fung, J., Weier, H. U., Cheng, J. F., and Rubin, E. M. (1997) Nat. Genet. 16, 28-36[CrossRef][Medline] [Order article via Infotrieve]
24. Altafaj, X., Dierssen, M., Baamonde, C., Martí, E., Visa, J., Guimerà, J., Oset, M., González, J. R., Flórez, J., Fillat, C., and Estivill, X. (2001) Hum. Mol. Genet. 10, 1915-1923[Abstract/Free Full Text]
25. Himpel, S., Tegge, W., Frank, R., Leder, S., Joost, H. G., and Becker, W. (2000) J. Biol. Chem. 275, 2431-2438[Abstract/Free Full Text]
26. Woods, Y. L., Cohen, P., Becker, W., Jakes, R., Goedert, M., Wang, X., and Proud, C. G. (2001) Biochem. J. 355, 609-615[CrossRef][Medline] [Order article via Infotrieve]
27. Woods, Y. L., Rena, G., Morrice, N., Barthel, A., Becker, W., Guo, S., Unterman, T. G., and Cohen, P. (2001) Biochem. J. 355, 597-607[CrossRef][Medline] [Order article via Infotrieve]
28. Yang, E. J., Ahn, Y. S., and Chung, K. C. (2001) J. Biol. Chem. 276, 39812-39824[Abstract/Free Full Text]
29. Sung, Y. J., Carter, M., Zhong, J. M., and Hwang, Y. W. (1995) Biochemistry 34, 3470-3477[CrossRef][Medline] [Order article via Infotrieve]
30. Yamamoto, R., Li, X., Winter, S., Francke, U., and Kilimann, M. W. (1995) Hum. Mol. Genet. 4, 265-268[Abstract/Free Full Text]
31. So, C. W., Caldas, C., Liu, M. M., Chen, S. J., Huang, Q. H., Gu, L. J., Sham, M. H., Wiedemann, L. M., and Chan, L. C. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 2563-2568[Abstract/Free Full Text]
32. Giachino, C., Lantelme, E., Lanzetti, L., Saccone, S., Bella Valle, G., and Migone, N. (1997) Genomics 41, 427-434[CrossRef][Medline] [Order article via Infotrieve]
33. Sontag, J. M., Fykse, E. M., Ushkaryov, Y., Liu, J. P., Robinson, P. J., and Südhof, T. C. (1994) J. Biol. Chem. 269, 4547-4554[Abstract/Free Full Text]
34. Horisberger, M. A., McMaster, G. K., Zeller, H., Wathelet, M. G., Dellis, J., and Content, J. (1990) J. Virol. 64, 1171-1181[Abstract/Free Full Text]
35. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
36. Ferrell, J. E., and Martin, G. S. (1991) Methods Enzymol. 200, 430-435[Medline] [Order article via Infotrieve]
37. Warnock, D. E., Terlecky, L. J., and Schmid, S. L. (1995) EMBO J. 14, 1322-1328[Medline] [Order article via Infotrieve]
38. Slepnev, V. I., Ochoa, G. C., Butler, M. H., Grabs, D., and De Camilli, P. (1998) Science 281, 821-824[Abstract/Free Full Text]
39. Valtorta, F., Schiebler, W., Jahn, R., Ceccarelli, B., and Greengard, P. (1986) Anal. Biochem. 158, 130-137[CrossRef][Medline] [Order article via Infotrieve]
40. McNiven, M. A., Cao, H., Pitts, K. R., and Yoon, Y. (2000) Trends Biochem. Sci. 25, 115-120[CrossRef][Medline] [Order article via Infotrieve]
41. Schmid, S. L., McNiven, M. A., and De Camilli, P. (1998) Curr. Opin. Cell Biol. 10, 504-512[CrossRef][Medline] [Order article via Infotrieve]
42. Ringstad, N., Nemoto, Y., and De Camilli, P. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 8569-8574[Abstract/Free Full Text]
43. Gout, I., Dhand, R., Hiles, I. D., Fry, M. J., Panayotou, G., Das, P., Truong, O., Totty, N. F., Hsuan, J., Booker, G. W., Campbell, I. D., and Waterfield, M. D. (1993) Cell 75, 25-36[CrossRef][Medline] [Order article via Infotrieve]
44. Hinshaw, J. E. (2000) Annu. Rev. Cell Dev. Biol. 16, 483-519[CrossRef][Medline] [Order article via Infotrieve]
45. Hinshaw, J. E., and Schmid, S. L. (1995) Nature 374, 190-192[CrossRef][Medline] [Order article via Infotrieve]
46. Takei, K., McPherson, P. S., Schmid, S. L., and De Camilli, P. (1995) Nature 374, 186-190[CrossRef][Medline] [Order article via Infotrieve]
47. Sweitzer, S. M., and Hinshaw, J. E. (1998) Cell 93, 1021-1029[CrossRef][Medline] [Order article via Infotrieve]
48. Marks, B., Stowell, M. H., Vallis, Y., Mills, I. G., Gibson, A., Hopkins, C. R., and McMahon, H. T. (2001) Nature 410, 231-235[CrossRef][Medline] [Order article via Infotrieve]
49. Sever, S., Muhlberg, A. B., and Schmid, S. L. (1999) Nature 398, 481-486[CrossRef][Medline] [Order article via Infotrieve]
50. David, C., McPherson, P. S., Mundigl, O., and De Camilli, P. (1996) Proc. Natl. Acad. Sci. U. S. A.